SCHEMBL24813283

SCHEMBL24813283

c1ccc(-n2c3ccccc3c3c(-c4ccc5c6ccccc6n(-c6ccc(-c7ccc(-c8ccc(-c9cccc%10c9oc9ccccc9%10)cc8)cc7)cc6)c5c4)cccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.46
▸ PRKDC P78527 4/20 0.40
▸ ATM Q13315 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ GGPS1 O95749 1/20 0.36
▸ PTGES2 Q9H7Z7 1/20 0.36
▸ HDAC4 P56524 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ BRCA1 P38398 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ PRMT5 O14744 1/20 0.33
▸ WDR77 Q9BQA1 1/20 0.33
▸ PPARG P37231 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.32
▸ NR2E3 Q9Y5X4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26788387 1.00 ALOX5 (0.46) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL26788492 1.00 ALOX5 (0.46) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL24811989 1.00 ALOX5 (0.46) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL21094915 0.99 ALOX5 (0.47) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL24812233 0.97 ALOX5 (0.49) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL24811845 0.94 ALOX5 (0.46) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL26788585 0.94 ALOX5 (0.46) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL24810492 0.93 ALOX5 (0.46) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL26788526 0.93 ALOX5 (0.38) ALOX5PRKDCATMKDM4EL3MBTL1
SCHEMBL24810878 0.92 KDM4E (0.41) ALOX5PRKDCATMKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 — — US disclosed
US-20230371373-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE ldemitsu Kosan Co.,Ltd. (JP) 2023-11-16 — — US disclosed
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 ALOX5 3499/4885PRKDC 3445/4885ATM 3436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback